Given the crucial roles of KDM4A in tumorigenesis and drug resistance, many pharmacologists and pharmaceutical chemists have been devoted to discovering and developing KDM4A inhibitors to combat KDM4A-mediated cancers. Here, KDM4A is linked to cancer.